BioCity Announces FDA Clearance of the Investigational New D

BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3

/PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND)...

Related Keywords

Yong Jiang , Zhejiang , China , Shanghai , Biocity Adcs , Prnewswire Biocity Biopharma , Linkedin Biocity Biopharma , Biocity Biopharma , Drug Administration , City Biopharma , Investigational New Drug , Yong Jiang Hei ,